Sarah J Nevitt

7.3k total citations · 1 hit paper
158 papers, 4.6k citations indexed

About

Sarah J Nevitt is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sarah J Nevitt has authored 158 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pediatrics, Perinatology and Child Health, 57 papers in Psychiatry and Mental health and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sarah J Nevitt's work include Epilepsy research and treatment (51 papers), Pharmacological Effects and Toxicity Studies (49 papers) and Cystic Fibrosis Research Advances (19 papers). Sarah J Nevitt is often cited by papers focused on Epilepsy research and treatment (51 papers), Pharmacological Effects and Toxicity Studies (49 papers) and Cystic Fibrosis Research Advances (19 papers). Sarah J Nevitt collaborates with scholars based in United Kingdom, United States and Australia. Sarah J Nevitt's co-authors include Catrin Tudur Smith, Anthony G Marson, Jennifer Weston, Eric Robinson, Andrew Jones, Richard Newton, E. Boyland, Thomas Radtke, Bridget Kelly and Jason C. G. Halford and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Sarah J Nevitt

143 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advertising as a cue to consume: a systematic review and meta-analysis of the effects of acute exposure to unhealthy food and nonalcoholic beverage advertising on intake in children and adults

2016 404 citations Sarah J Nevitt, Catrin Tudur Smith et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah J Nevitt United Kingdom	40	1.3k	1.0k	734	632	479	158	4.6k
Hilary Watt United Kingdom	39	867 0.7×	859 0.9×	379 0.5×	294 0.5×	497 1.0×	93	5.4k
Carla Bann United States	43	841 0.7×	2.2k 2.2×	1.1k 1.5×	1.2k 1.8×	1.2k 2.5×	214	8.5k
M. Daniele Fallin United States	54	1.2k 0.9×	1.3k 1.3×	571 0.8×	583 0.9×	960 2.0×	199	10.0k
Pim Brouwers United States	46	740 0.6×	1.1k 1.1×	801 1.1×	645 1.0×	476 1.0×	114	5.8k
George F. Borm Netherlands	44	1.1k 0.9×	393 0.4×	765 1.0×	437 0.7×	298 0.6×	118	8.1k
Barbara Sperner‐Unterweger Austria	42	684 0.5×	718 0.7×	574 0.8×	510 0.8×	306 0.6×	152	5.0k
Kirsten M. Fiest Canada	44	3.0k 2.4×	1.6k 1.6×	739 1.0×	422 0.7×	1.0k 2.1×	221	9.1k
Linda J Lux United States	35	715 0.6×	700 0.7×	1.2k 1.7×	292 0.5×	633 1.3×	102	7.0k
Lorenzo Cohen United States	50	741 0.6×	1.4k 1.3×	1.2k 1.6×	1.2k 1.9×	1.0k 2.1×	254	9.4k
Elizabeth Thompson United Kingdom	39	502 0.4×	486 0.5×	374 0.5×	332 0.5×	312 0.7×	200	4.6k

Countries citing papers authored by Sarah J Nevitt

Since Specialization

Citations

This map shows the geographic impact of Sarah J Nevitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah J Nevitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah J Nevitt more than expected).

Fields of papers citing papers by Sarah J Nevitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah J Nevitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah J Nevitt. The network helps show where Sarah J Nevitt may publish in the future.

Co-authorship network of co-authors of Sarah J Nevitt

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah J Nevitt. A scholar is included among the top collaborators of Sarah J Nevitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah J Nevitt. Sarah J Nevitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Russo, Marc, Sarah J Nevitt, Danielle M. Santarelli, Sam Eldabe, & Rui Duarte. (2025). Systematic review and meta-analysis of conventional medical management in a patient population with refractory chronic pain suitable to receive a spinal cord stimulation system. Pain Medicine. 26(6). 337–347. 2 indexed citations

Walton, Matthew, Mark Corbett, Sarah J Nevitt, et al.. (2025). The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHS. The European Journal of Health Economics.

Fleeman, Nigel, Rachel Houten, Sarah J Nevitt, et al.. (2024). Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis. Health Technology Assessment. 28(49). 1–190.

Dobbie, Laurence J., Jamie Burgess, Sarah J Nevitt, et al.. (2024). Effect of a Low-Calorie Dietary Intervention on Liver Health and Body Weight in Adults with Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Overweight/Obesity: A Systematic Review and Meta-Analysis. Nutrients. 16(7). 1030–1030. 11 indexed citations

Nevitt, Sarah J, David Phillippo, Robert Hodgson, Nicky J. Welton, & Sofia Dias. (2024). Application of Multi-level Network Meta-Regression in the NICE Technology Appraisal of Quizartinib for Induction, Consolidation and Maintenance Treatment of Newly Diagnosed FLT3-ITD-Positive Acute Myeloid Leukaemia: An External Assessment Group Perspective. PharmacoEconomics. 43(3). 243–247.

Bresnahan, Rebecca, Rui Duarte, James Mahon, et al.. (2023). Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation. Health Technology Assessment. 27(10). 1–115. 4 indexed citations

Bresnahan, Rebecca, Rachel Houten, J Greenhalgh, et al.. (2023). Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics - Open. 7(4). 525–536.

Eldabe, Sam, Sarah J Nevitt, Michelle Maden, et al.. (2023). Does industry funding and study location impact findings from randomized controlled trials of spinal cord stimulation? A systematic review and meta-analysis. Regional Anesthesia & Pain Medicine. 49(4). 272–284. 11 indexed citations

Duarte, Rui, Sarah J Nevitt, Michelle Maden, et al.. (2022). Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy. Diabetes Care. 45(10). 2466–2475. 13 indexed citations

10.

Maishman, Tom, et al.. (2022). Statistical methods used to combine the effective reproduction number, R(t), and other related measures of COVID-19 in the UK. Statistical Methods in Medical Research. 31(9). 1757–1777. 17 indexed citations

11.

Henderson, J.R., et al.. (2021). Systematic Review of the Effectiveness of Machine Learning Algorithms for Classifying Pain Intensity, Phenotype or Treatment Outcomes Using Electroencephalogram Data. Journal of Pain. 23(3). 349–369. 19 indexed citations

12.

Kirthi, Varo, Paul Nderitu, Uazman Alam, et al.. (2021). Prevalence of retinopathy in prediabetes: protocol for a systematic review and meta-analysis. BMJ Open. 11(1). e040997–e040997. 7 indexed citations

13.

Nevitt, Sarah J, et al.. (2020). Mindfulness‐based cognitive therapy for prevention and time to depressive relapse: Systematic review and network meta‐analysis. Acta Psychiatrica Scandinavica. 143(1). 6–21. 42 indexed citations

14.

Eleftheriadou, Aikaterini, S. Williams, Sarah J Nevitt, et al.. (2020). The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review. Diabetologia. 64(2). 288–303. 39 indexed citations

15.

Noble, Adam, Dee Snape, Sarah J Nevitt, et al.. (2020). Seizure First Aid Training For people with Epilepsy (SAFE) frequently attending emergency departments and their significant others: results of a UK multi-centre randomised controlled pilot trial. BMJ Open. 10(4). e035516–e035516. 3 indexed citations

16.

Southern, Kevin W, et al.. (2019). A systematic Cochrane Review of correctors (specific therapies for class II CFTR mutations) for cystic fibrosis. Paediatric Respiratory Reviews. 30. 25–26. 2 indexed citations

17.

Duarte, Rui, Angela Stainthorpe, J Greenhalgh, et al.. (2019). The clinical and cost effectiveness of lead-I electrocardiogram (ECG) devices for detecting atrial fibrillation using single-time point testing in primary care: a systematic review and economic evaluation. Health Technology Assessment. 1 indexed citations

18.

Nevitt, Sarah J, Judith Thornton, Clare Murray, & Tiffany Dwyer. (2018). Inhaledmannitol for cystic fibrosis (Review). Research Explorer (The University of Manchester). 1 indexed citations

19.

West, Siobhan, Sarah J Nevitt, & Richard Newton. (2016). Surgery for epilepsy: a systematic review of current evidence. Epileptic Disorders. 18(2). 113–121. 51 indexed citations

20.

Nevitt, Sarah J, Ian Hambleton, & Kerry Dwan. (2016). The Use and Reporting of the Cross-Over Study Design in Clinical Trials and Systematic Reviews: A Systematic Assessment. PLoS ONE. 11(7). e0159014–e0159014. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact